Culture

Culture · Biography

1955–

Brian Kobilka

Brian Kobilka moved from medical training into receptor research with Robert Lefkowitz, then pursued the difficult structural study of GPCRs at Stanford.

United States Little Falls, Minnesota, United States Updated 7 November 2026
Photo pending permission
In this biography

Quick facts

Born
30 May 1955
Birthplace
Little Falls, Minnesota, United States
Nationality
Not independently established
Known for
Investigating G-protein-coupled receptors from gene identification to structures of activation complexes

Why this life matters

His work connects a receptor’s molecular architecture with the coupling events that help transmit a signal across a cell membrane.

Timeline

Key moments

  1. Born in Little Falls

    Kobilka was born on 30 May.

  2. Moved to Stanford

    Established a receptor research programme there.

  3. Receptor–Gs structure

    A wide collaboration reported an active-state complex.

Medicine supplied the questions

Brian Kent Kobilka was born in Little Falls, Minnesota, in 1955. He studied at the University of Minnesota Duluth, earned his medical degree at Yale and completed clinical training in St. Louis. His autobiography describes an interest in intensive-care medicine, where drugs acting on cell-surface receptors could rapidly change heart rate, blood pressure and pain. That experience helped direct him toward research: he wanted to understand the basic systems through which such agents produced their effects, rather than only learn which treatment to administer.

Sources for this section: [4] · [3]

A research apprenticeship with Lefkowitz

Kobilka joined Robert Lefkowitz’s laboratory at Duke, where he worked on adrenergic receptors. The programme connected biochemical receptor identification with molecular information about the proteins. Kobilka’s work helped reveal relationships between an adrenergic receptor and other members of what became the GPCR family. He moved to Stanford in 1989 and continued studying receptor structure and behaviour. The partnership with Lefkowitz was therefore an important early phase, but the later structural programme involved a new set of technical challenges and collaborators.

Sources for this section: [4] · [3]

Capturing a specific signalling complex

The 2011 structure paper reported an agonist-occupied β2-adrenergic receptor bound to a nucleotide-free Gs heterotrimer. The authors described interactions at the interface and conformational changes connecting the receptor with the nucleotide-binding region. This was a specific captured molecular assembly, not a complete film of every activation event in living cells. The large author list reflects the combined work needed to prepare, stabilise and analyse such a complex. It also makes it important to credit the team rather than attributing every experimental contribution to the head of the laboratory.

Sources for this section: [1] · [2]

Recognition for connecting receptors with mechanism

Kobilka shared the 2012 Nobel Prize in Chemistry with Lefkowitz for studies of G-protein-coupled receptors. Their careers traced different stages of a programme that made receptors experimentally accessible. Binding studies, sequence relationships and structures each supplied a different kind of evidence. Kobilka’s structural work helped explain how a receptor could communicate across the membrane, but it did not make one crystal structure an assay of every cellular response. The legacy is stronger when the captured state, its collaborators and its connection to functional experiments remain explicit.

Sources for this section: [3] · [2]

Quick answers

Frequently asked questions about Brian Kobilka

Who was Brian Kobilka’s Nobel Prize partner?
Robert Lefkowitz shared the 2012 chemistry prize with Kobilka for studies of GPCRs.
What did the 2011 receptor structure contain?
It contained an agonist-occupied β2-adrenergic receptor and a nucleotide-free Gs heterotrimer, a specific signallingcomplex.

Keep exploring

Lives connected to this story

  • Robert F. Furchgott

    Compare another investigation of cell signalling, while keeping nitric-oxide signalling distinct from GPCR activation.

Sources and further reading

Explore the evidence

These references support the biography and offer further reading. Official records, first-person accounts and independent reporting provide different perspectives; image records document attribution and licensing.

  1. 1. Rasmussen and colleagues / NatureCrystal structure of the β2-adrenergic receptor–Gs protein complex

    Online publication was19 July 2011; the journal issue followed in September. These datesrefer to different publication stages, not differentexperiments.

  2. 2. Brian K.Kobilka / Trends in Pharmacological SciencesStructural insights into adrenergic receptor function and pharmacology
  3. 3. Nobel Prize OutreachBrian Kobilka — Facts
  4. 4. Nobel Prize OutreachBrian Kobilka — Biographical
Back to top ↑